Literature DB >> 21666339

Recurrent autoimmune hypophysitis successfully treated with glucocorticoids plus azathioprine: a report of three cases.

Guo-Qing Yang1, Zhao-Hui Lu, Wei-Jun Gu, Jin Du, Qing-Hua Guo, Xian-Ling Wang, Jian-Ming Ba, Jing-Tao Dou, Yi-Ming Mu, Ju-Ming Lu.   

Abstract

Recurrent autoimmune hypophysitis is a rare autoimmune endocrine disease involving lymphocytic infiltration and chronic pituitary inflammation. It is even more rare than primary hypophysitis. The objective of the study was to evaluate the efficacy of glucocorticoid treatment combined with azathioprine for treating three cases of recurrent autoimmune lymphocytic hypophysitis encountered within a two-year period. The clinical features and follow-up data of these cases were analyzed, including results of treatment with glucocorticoids combined with azathioprine. All three patients were female and presented with the following clinical characteristics: case 1 was a 22-year-old with headache and diplopia; case 2 was a 70-year-old with dry mouth, polydipsia, and polyuria; case 3, a 32-year-old, with polydipsia, polyuria and menstrual disorders with headache and dizziness. Regarding recurrence, case 1 recurred 4 months after surgery and again 14 months after discontinuing prednisone; case 2 relapsed 16 months after receiving high-dose methylprednisolone pulse therapy; and case 3 recurred during the period of prednisone dose reduction. The patients were treated with glucocorticoids plus azathioprine, and positive responses were seen in all three cases. Symptoms were relieved, and MRI revealed significant reduction of lesions during follow-up. Pituitary function resumed in cases 1 and 3; permanent hypopituitarism was present in case 2. At last follow-up, MRI showed no further recurrence of disease in any patient. Treatment and responses of these patients with autoimmune hypophysitis suggest that glucocorticoid therapy combined with azothioprine is effective treatment for recurrent autoimmune hypophysitis. Endocrine and radiologic studies are an essential part of follow-up.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21666339     DOI: 10.1507/endocrj.k10e-334

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

1.  Hypophysitis: a single-center case series.

Authors:  Brandon S Imber; Han S Lee; Sandeep Kunwar; Lewis S Blevins; Manish K Aghi
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

Review 2.  Granulomatous hypophysitis causing compression of the internal carotid arteries reversible with azathioprine and rituximab treatment.

Authors:  Pauline Gendreitzig; Jürgen Honegger; Marcus Quinkler
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

3.  Successful diagnosis of hypothalamitis using stereotactic biopsy and treatment: a case report.

Authors:  Shuo Zhang; Hongying Ye; Zhaoyun Zhang; Bin Lu; Yehong Yang; Min He; Hanfeng Wu; Linuo Zhou; Yin Wang; Li Pan; Yiming Li; Renming Hu
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

4.  Paraneoplastic limbic encephalitis with associated hypothalamitis mimicking a hyperdense hypothalamic tumor: a case report.

Authors:  Vipula R Bataduwaarachchi; Nirmali Tissera
Journal:  BMC Med Imaging       Date:  2016-01-18       Impact factor: 1.930

5.  Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil.

Authors:  Mike Lin; Venessa Tsang; Janice Brewer; Roderick Clifton-Bligh; Matti L Gild
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-07-29

6.  Recurrent autoimmune hypophysitis treated with rituximab: a case report.

Authors:  Maria Kruse; Thomas Bastholm Olesen; Ljubo Markovic; Dorte Glintborg; Marianne Skovsager Andersen
Journal:  J Med Case Rep       Date:  2021-12-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.